文献速递甲状腺疾病

甲状腺半发育不全:发病率、临床意义与遗传背景

Thyroid Hemiagenesis: Incidence, Clinical Significance, and Genetic Background.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

本文通过检索PubMed数据库(1970年至2017年),综述甲状腺半发育不全(THA)的发病率、临床意义与遗传背景。文章指出THA患者易发生其他甲状腺及非甲状腺病变,慢性促甲状腺激素升高可能起重要作用,但遗传学研究尚未发现共同遗传背景,仅少数病例找到潜在病因。作者认为患者理论上可能从左甲状腺素治疗中获益,但需进一步研究证实早期干预能否预防相关甲状腺疾病。

要点

  • THA患者易发生其他甲状腺及非甲状腺病变,慢性TSH升高可能参与伴发甲状腺病变的发病。
  • 遗传学研究尚未发现THA的共同遗传背景,仅少数病例找到潜在病因。
  • 作者认为THA患者理论上可能从左甲状腺素治疗中获益以降低TSH至正常人群水平,但需进一步研究证实。

核心结论

  • THA患者易发生其他甲状腺病变,理论上可能从左甲状腺素治疗中获益以降低促甲状腺激素水平至正常人群水平,但需进一步研究确定早期干预能否预防相关甲状腺疾病。
  • 随访检查中至少应保持高度警惕以尽早发现所有伴发疾病,应用高通量技术进行全基因组搜索可能有助于扩展对THA发病机制的认识。

研究设计与样本

  • 证据获取:检索PubMed数据库(1970年至2017年),检索词为「thyroid hemiagenesis」「thyroid hemiaplasia」「one thyroid lobe agenesis」「one thyroid lobe aplasia」,并检索所获文章的参考文献部分。

主要发现

  • THA患者对发生其他甲状腺及非甲状腺病变具有明显易感性。
  • 在伴发甲状腺病变的发病机制中,促甲状腺激素值的慢性升高可能起重要作用。
  • 迄今遗传学研究未能发现该异常的常见遗传背景,仅在少数病例中确定了潜在病因。

临床怎么用

  • 作者认为THA患者理论上可能从左甲状腺素治疗中获益,以将促甲状腺激素水平降至正常人群中所观察到的水平。
  • 作者建议在随访检查中保持高度警惕,以尽早发现所有伴发疾病。

局限性

  • 遗传学研究迄今未能发现该异常的常见遗传背景,仅在少数病例中确定了潜在病因。
  • 作者指出需进一步研究以确定早期左甲状腺素干预能否预防相关甲状腺疾病的发生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Thyroid hemiagenesis (THA) constitutes a rare, congenital disorder that is characterized by an absence of one thyroid lobe. Because the pathogenesis and clinical significance of this malformation remain undefined, specific clinical recommendations are lacking, especially for asymptomatic cases. EVIDENCE ACQUISITION: The PubMed database was searched (years 1970 to 2017), and the following terms were used to retrieve the results: "thyroid hemiagenesis," "thyroid hemiaplasia," "one thyroid lobe agenesis," and "one thyroid lobe aplasia." Subsequently, reference sections of the retrieved articles were searched. EVIDENCE SYNTHESIS: There is a noticeable susceptibility of subjects with THA to develop additional thyroid and nonthyroidal pathologies. In pathogenesis of concomitant thyroid pathologies, a chronic elevation in thyroid-stimulating hormone values may play an important role. Thus far, genetic studies failed to find a common genetic background of the anomaly, and the potential underlying cause was identified in a minority of the cases. CONCLUSIONS: Patients with THA are prone to develop additional thyroid pathologies and theoretically might benefit from l-thyroxine treatment to lower the thyrotropin levels to those observed in the normal population. However, further research should be done to ascertain whether such intervention early in life would prevent development of associated thyroid conditions. At least, increased vigilance should be maintained to reveal all of the concomitant disorders as soon as possible during follow-up examinations. Application of high-throughput technologies enabling a genome-wide search for novel factors involved in thyroid embryogenesis might be the next step to expand the knowledge on THA pathogenesis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Szczepanek-Parulska E, Zybek-Kocik A, Wartofsky L, et al. Thyroid Hemiagenesis: Incidence, Clinical Significance, and Genetic Background. J Clin Endocrinol Metab. 2017. PMID: 28666345. doi:10.1210/jc.2017-00784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。